Boston Scientific Corp (XTER:BSX)
€ 86.5 -0.5 (-0.57%) Market Cap: 126.52 Bil Enterprise Value: 134.81 Bil PE Ratio: 74.93 PB Ratio: 6.45 GF Score: 79/100

Boston Scientific Corp at SVB Leerink Global Healthcare (Virtual) Transcript

Feb 17, 2022 / 02:20PM GMT
Release Date Price: €38.26 (+0.16%)
Danielle Joy Antalffy
SVB Leerink LLC, Research Division - MD of Medical Supplies and Devices & Senior Analyst

Good morning, everyone. Thank you for joining us for day 2 of the company fireside chat for the SVB Leerink Global Healthcare Conference. I am Danielle Antalffy. I'm the med tech analyst here at Leerink, and we are very lucky to have with us Boston Scientific. We have Dan Brennan, CFO; and also Lauren Tengler, Head of Investor Relations. So I will just launch right into Q&A. Dan, if that's okay.

Daniel J. Brennan
Boston Scientific Corporation - Executive VP & CFO

Sure.

Questions & Answers

Danielle Joy Antalffy
SVB Leerink LLC, Research Division - MD of Medical Supplies and Devices & Senior Analyst

So let's start with 2022 guidance, the sense is that it did disappoint some, but you have historically tried to be as conservative as possible. Tell me if I'm wrong in characterizing it that way. But can you talk about your approach to arriving at the 2022 sales growth and EPS guidance

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot